Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

439
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
439
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

364
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
364
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

2.8K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
2.8K
Energy Balance01:19

Energy Balance

1.5K
The human body gets energy from the three macronutrients: carbohydrates, proteins, and fats. Energy is released when the chemical bonds in the organic compounds present in the food are broken down. The energy content of food is measured in kilocalories (kcal), defined as the amount of heat required to raise the temperature of one kilogram of water by one degree Celsius. This value is determined by measuring the temperature change of the water surrounding a calorimeter after the complete...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel oral agents in anti-obesity pharmacotherapy: A narrative review.

Diabetes, obesity & metabolism·2025
Same author

Effects of Intranasal Naloxone on Hypoglycemia-associated Autonomic Failure in Susceptible Individuals.

The Journal of clinical endocrinology and metabolism·2024
Same author

Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU.

The New England journal of medicine·2023
Same author

An Atypical Form of Diabetes Among Individuals With Low BMI.

Diabetes care·2022
Same author

Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice.

Molecular metabolism·2020
Same author

Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure.

The Journal of clinical endocrinology and metabolism·2020

Related Experiment Video

Updated: Apr 28, 2026

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

2.1K

Is there a paradox in obesity?

Akankasha Goyal1, Kameswara Rao Nimmakayala, Joel Zonszein

  • 1From the *Department of Medicine, Division of Endocrinology and Metabolism, Montefiore Medical Center, Bronx, NY; and †Department of Internal Medicine, Mount Vernon Hospital Center, Mount Vernon, NY.

Cardiology in Review
|June 5, 2014
PubMed
Summary

The "obesity paradox" may stem from a misunderstanding of adipose tissue. Body mass index (BMI) doesn't distinguish fat types, and fit individuals with higher BMI may have better outcomes.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.9K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

2.1K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.9K

Area of Science:

  • Cardiovascular Science
  • Metabolic Health
  • Obesity Research

Background:

  • Rising obesity rates correlate with increased morbidity and mortality.
  • The "obesity paradox" suggests obese individuals may have better outcomes despite comorbidities.
  • Current research often overlooks adiposity type, quantity, and disease severity.

Purpose of the Study:

  • To review the complex role of adipose tissue in cardiovascular disease.
  • To explore the metabolic implications of different adiposity types.
  • To critically examine the concept of the "obesity paradox".

Main Methods:

  • Literature review focusing on adipose tissue biology and cardiovascular outcomes.
  • Analysis of the limitations of body mass index (BMI) in obesity assessment.
  • Discussion of the pathophysiology linking adiposity, inflammation, and cardiovascular risk.

Main Results:

  • Adipose tissue characteristics (location, function) significantly impact metabolic health.
  • Visceral obesity is linked to inflammation and poorer metabolic profiles.
  • High BMI with functional adiposity may be associated with lower mortality risk.

Conclusions:

  • The "obesity paradox" may be an oversimplification due to a lack of understanding of adipose tissue complexity.
  • Adiposity type and function are critical factors in cardiovascular morbidity and mortality.
  • Further research is needed to elucidate the intricate relationship between obesity, adiposity, and health outcomes.